Breast cancer is a major disease with high morbidity and mortality in women worldwide.
Increased use of imaging biomarkers has been shown to add more information with clinical …

Breast cancer is the most frequent cancer diagnosed in women worldwide. Accurate
baseline staging is necessary to plan optimal breast cancer management. Early detection …

Invasive lobular carcinoma (ILC) demonstrates lower conspicuity on 18F-FDG PET than the
more common invasive ductal carcinoma. Other molecular imaging methods may be needed …

OBJECTIVE. FDG PET/CT affects the management of patients with breast cancer in multiple
settings, including initial staging, treatment response assessment, and evaluation of …

Breast cancer prognosis is steadily improving due to early detection of primary cancer in
screening programs and revolutionizing treatment development. In the metastatic setting …

Objectives To compare the diagnostic performance of [18F] FDG PET/MRI, MRI, CT, and
bone scintigraphy for the detection of bone metastases in the initial staging of primary breast …

Importance There are insufficient data comparing 16α-18 F-fluoro-17β-estradiol (FES)
positron emission tomography (PET) computed tomography (CT) with standard-of-care …

Purpose The aim of this study was to compare fluorodeoxyglucose positron emission
tomography/computed tomography (FDG PET/CT) and contrast-enhanced computed …

We compared lesion-based sensitivity of dual-time-point FDG-PET/CT, bone scintigraphy
(BS), and low-dose CT (LDCT) for detection of various types of bone metastases in patients …

Purpose To provide an organized, international, state-of-the-art, and multidisciplinary
guideline, led by experts of two nuclear medicine societies (EANM and SNMMI) and …